Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2014 | 1 |
2015 | 1 |
2023 | 2 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Did you mean
mayumi suzuki
(58 results)?
Model for classification of heart failure severity in patients with hypertrophic cardiomyopathy using a deep neural network algorithm with a 12-lead electrocardiogram.
Open Heart. 2023 Dec 6;10(2):e002414. doi: 10.1136/openhrt-2023-002414.
Open Heart. 2023.
PMID: 38056911
Free PMC article.
Machine learning-based detection of sleep-disordered breathing in hypertrophic cardiomyopathy.
Akita K, Kageyama S, Suzuki S, Ohno K, Kamakura M, Nawada R, Takanaka C, Wakabayashi Y, Kanda T, Tawarahara K, Mutoh M, Matsunaga M, Suwa S, Takeuchi Y, Sakamoto H, Saito H, Hayashi K, Wakahara N, Unno K, Ikoma T, Sato R, Iguchi K, Satoh T, Sano M, Suwa K, Naruse Y, Ohtani H, Saotome M, Maekawa Y; Searching for Atrial Fibrillation and Early Recruitment of Heart Failure in HCM (SAFER-HCM) Registry Investigators.
Akita K, et al. Among authors: suzuki s.
Heart. 2024 Apr 8:heartjnl-2023-323856. doi: 10.1136/heartjnl-2023-323856. Online ahead of print.
Heart. 2024.
PMID: 38589224
Item in Clipboard
Association of Malnutrition and High Bleeding Risk with Long-Term Prognosis in Patients with Acute Coronary Syndrome following Percutaneous Coronary Intervention.
Kataoka H, Suzuki S, Suzuki Y, Sato R, Sano M, Mogi S, Sakamoto A, Suwa K, Naruse Y, Ohtani H, Saotome M, Shimizu M, Odagiri K, Maekawa Y.
Kataoka H, et al. Among authors: suzuki s.
Medicines (Basel). 2023 Nov 30;10(12):62. doi: 10.3390/medicines10120062.
Medicines (Basel). 2023.
PMID: 38132889
Free PMC article.
Item in Clipboard
Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells.
Sato H, Siddig S, Uzu M, Suzuki S, Nomura Y, Kashiba T, Gushimiyagi K, Sekine Y, Uehara T, Arano Y, Yamaura K, Ueno K.
Sato H, et al. Among authors: suzuki s.
Eur J Pharmacol. 2015 Jan 5;746:258-66. doi: 10.1016/j.ejphar.2014.11.021. Epub 2014 Nov 29.
Eur J Pharmacol. 2015.
PMID: 25455500
Item in Clipboard
Cite
Cite